0610007N19Rik Activators
RIKEN cDNA 0610007N19 gene product activators encompass a variety of chemical compounds that exert their effects by manipulating intracellular signaling cascades, ultimately leading to the enhancement of the protein's activity. Compounds such as Forskolin, IBMX, and Isoproterenol elevate intracellular cAMP levels, which in turn activate PKA, a key enzyme capable of phosphorylating various substrates to fine-tune cellular processes that RIKEN cDNA 0610007N19 gene product is involved with. RIKEN cDNA 0610007N19 gene product activators encompass a variety of chemical compounds that exert their effects by manipulating intracellular signaling cascades, ultimately leading to the enhancement of the protein's activity. Compounds such as Forskolin, IBMX, and Isoproterenol elevate intracellular cAMP levels, which in turn activate PKA, a key enzyme capable of phosphorylating various substrates to fine-tune cellular processes that RIKEN cDNA 0610007N19 gene product is involved with.
Further diversifying the modes of activation, 8-Br-cAMP, a cAMP analog, also serves to activate PKA, suggesting a reinforced pathway of enhancement for the RIKEN cDNA 0610007N19 gene product through similar yet distinct mechanisms as Forskolin and Isoproterenol. The increase in cGMP levels by Sildenafil and Zaprinast, through inhibition of phosphodiesterase 5, offers an alternate route for activation via PKG signaling pathways. On another front, nicotinic acid can modulate G-protein-coupled receptor signaling, potentially leading to the activation of downstream effectors that enhance the RIKEN cDNA 0610007N19 gene product's activity. Finally, BAY 60-6583, by acting as an adenosine A2B receptor agonist and raising cAMP levels, provides an additional layer of regulatory influence that could converge on the pathways involving the RIKEN cDNA 0610007N19 gene product, ensuring its enhanced activity through multifaceted signaling dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, thereby raising cAMP levels and potentially enhancing the activity of RIKEN cDNA 0610007N19 gene product through cAMP-mediated signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may lead to the phosphorylation of proteins and signaling cascades that indirectly increase the activity of RIKEN cDNA 0610007N19 gene product by modifying its interaction with other cellular components. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially enhancing the activity of RIKEN cDNA 0610007N19 gene product through calcium-dependent signaling mechanisms. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts similarly to ionomycin as a calcium ionophore, raising intracellular calcium and possibly enhancing RIKEN cDNA 0610007N19 gene product activity by activating calcium-dependent proteins and pathways. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates PKA, potentially leading to the enhanced activity of RIKEN cDNA 0610007N19 gene product through phosphorylation events and activation of PKA-dependent signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can raise cAMP levels, thereby potentially enhancing the activity of RIKEN cDNA 0610007N19 gene product through cAMP-mediated PKA activation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, resulting in increased cAMP levels, which could indirectly enhance RIKEN cDNA 0610007N19 gene product activity through cAMP-dependent pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, particularly PDE5, increasing cGMP levels and potentially enhancing the activity of RIKEN cDNA 0610007N19 gene product via the cGMP-PKG signaling axis. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Nicotinic acid, or niacin, can influence G-protein coupled receptors to modulate intracellular signaling cascades, potentially enhancing the activity of RIKEN cDNA 0610007N19 gene product through these pathways. | ||||||
BAY 60-6583 | 910487-58-0 | sc-503262 | 10 mg | $210.00 | ||
BAY 60-6583 is an adenosine A2B receptor agonist that can increase cAMP levels, potentially leading to the enhancement of RIKEN cDNA 0610007N19 gene product activity through A2B receptor-mediated signaling pathways. | ||||||